Oral valganciclovir as preemptive therapy for Cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients | AVESİS

Bursa Uludag University Research Information System

Oral valganciclovir as preemptive therapy for Cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients

Copy For Citation

ÖZKOCAMAN V., ÖZKALEMKAŞ F., ALİ R.

56th American Society of hematology, San-Francisco, Costa Rica, 06 December 2014

Publication Type: Conference Paper / Full Text
City: San-Francisco
Country: Costa Rica
Bursa Uludag University Affiliated: Yes